SCHEMBL18560556

SCHEMBL18560556

CC(C[C@H](NC(=O)OC(C)(C)C)C(=O)O)C(=O)O

nearest known ligand 0.59

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ NAALAD2 Q9Y3Q0 3/20 0.59
▸ FOLH1 Q04609 2/20 0.59
▸ CTSK P43235 6/20 0.52
▸ CTSS P25774 5/20 0.52
▸ CTSL P07711 2/20 0.52
▸ CTSB P07858 1/20 0.52
▸ CA1 P00915 1/20 0.47
▸ CA2 P00918 1/20 0.47
▸ CA7 P43166 1/20 0.47
▸ PPARA Q07869 5/20 0.46
▸ PPARG P37231 4/20 0.46
▸ CAPN1 P07384 1/20 0.46
▸ ACE P12821 1/20 0.45
▸ PPARD Q03181 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1319454 1.00 NAALAD2 (0.59) NAALAD2FOLH1CTSKCTSSCTSL
SCHEMBL7954021 1.00 NAALAD2 (0.59) NAALAD2FOLH1CTSKCTSSCTSL
SCHEMBL7066210 1.00 NAALAD2 (0.59) NAALAD2FOLH1CTSKCTSSCTSL
SCHEMBL20745305 1.00 NAALAD2 (0.59) NAALAD2FOLH1CTSKCTSSCTSL
SCHEMBL13263380 1.00 NAALAD2 (0.59) NAALAD2FOLH1CTSKCTSSCTSL
SCHEMBL28804956 0.90 CTSK (0.50) NAALAD2FOLH1CTSKCTSSCTSL
SCHEMBL28804957 0.90 CTSK (0.50) NAALAD2FOLH1CTSKCTSSCTSL
SCHEMBL27844888 0.89 CTSK (0.57) NAALAD2FOLH1CTSKCTSSCTSL
SCHEMBL30174879 0.89 CTSK (0.49) NAALAD2FOLH1CTSKCTSSCTSL
SCHEMBL13293190 0.89 CTSK (0.49) NAALAD2FOLH1CTSKCTSSCTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2953932-B1 SUBSTITUTED CARBOXYLIC ACID DERIVATIVES AS AGGRECANASE INHIBITORS FOR THE TREATMENT OF OSTEOARTHRITIS MERCK PATENT GMBH (DE) 2017-03-01 — — EP disclosed
CN-102206247-B Novel peptides as NS3/NS4a serine protease inhibitors of hepatitis C virus DENDREON CORP 2013-03-27 — — CN disclosed
Send feedback